Examination of the effect of acute levodopa administration on the loudness dependence of auditory evoked potentials (LDAEP) in humans

Psychopharmacology

Volumn 221, Issue 3, 2012, Pages 389-396

  Hitz, K ^a   Heekeren, K ^a   Obermann, C ^a   Huber, T ^b   Juckel, G ^c   Kawohl, W ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Dopamine; Levodopa; Loudness dependence auditory evoked potentials (LDAEP); Primary auditory cortex; Serotonin

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; BIOLOGICAL MARKER; DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PLACEBO;

ACUTE DRUG ADMINISTRATION; ARTICLE; CONTROLLED STUDY; CRONBACH ALPHA COEFFICIENT; DOPAMINERGIC TRANSMISSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EVENING DOSAGE; EVOKED AUDITORY RESPONSE; FEMALE; GENETIC ASSOCIATION; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; LOUDNESS DEPENDENCE OF AUDITORY EVOKED POTENTIAL; MALE; NAUSEA; NON INVASIVE MEASUREMENT; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC SYSTEM; SINGLE DRUG DOSE; TEST RETEST RELIABILITY;

ADMINISTRATION, ORAL; ADULT; BENSERAZIDE; DOPAMINE AGENTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LEVODOPA; LOUDNESS PERCEPTION; MALE; YOUNG ADULT;

EID: 84862683592     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2586-8     Document Type: Article

References (42)

1. Axelrod J, Tomchick R (1958) Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 233:702-705
2. Baribeau JC, Laurent JP (1987) The effect of selective attention on augmenting/intensity function of the early negative waves of AEPs. Electroencephalogr Clin Neurophysiol Suppl 40:68-75
3. Black KJ, Mink JW (2000) Response to levodopa challenge in Tourette syndrome. Mov Disord 15:1194-1198
4. Brocke B, Beauducel A, John R, Debener S, Heilemann H (2000) Sensation seeking and affective disorders: characteristics in the intensity dependence of acoustic evoked potentials. Neuropsychobiology 41:24-30 (Pubitemid 30025908)
5. Cohen J (1992) A power primer. Psychol Bull 112(1):155-159
6. de la Fuente-Fernandez R, Sossi V, Huang Z, Furtado S, Lu JQ, Calne DB, Ruth TJ, Stoessl AJ (2004) Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. Brain 127:2747-2754
7. Ebstein RP, Benjamin J, Belmaker RH (2000) Personality and polymorphisms of genes involved in aminergic neurotransmission. Eur J Pharmacol 410:205-214 (Pubitemid 32008144)
8. Floel A, Breitenstein C, Hummel F, Celnik P, Gingert C, Sawaki L, Knecht S, Cohen LG (2005) Dopaminergic influences on formation of a motor memory. Ann Neurol 58:121-130 (Pubitemid 40962467)
9. Funke B, Malhotra AK, Finn CT, Plocik AM, Lake SL, Lencz T, DeRosse P, Kane JM, Kucherlapati R (2005) COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav Brain Funct 1:19
10. Gallinat J, Bottlender R, Juckel G, Munke-Puchner A, Stotz G, Kuss HJ, Mavrogiorgou P, Hegerl U (2000) The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl) 148:404-411 (Pubitemid 30169759)
11. Hagenmuller F, Hitz K, Darvas F, Kawohl W (2011) Determination of the Loudness Dependence of Auditory Evoked Potentials (LDAEP): single electrode estimation versus dipole source analysis. Hum Psychopharmacol Clin Exp 26:147-154
12. Hegerl U (1994) Event-related potentials in psychiatry: a new perspective. Pharmacopsychiatry 27:47-48
13. Hegerl U, Juckel G (1993) Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 33:173-187 (Pubitemid 23089966)
14. Hegerl U, Juckel G (1994) Auditory evoked dipole source activity: indicator of central serotonergic dysfunction in psychiatric patients? Pharmacopsychiatry 27:75-78 (Pubitemid 24108952)
15. Hegerl U, Juckel G (2000) Identifying psychiatric patients with serotonergic dysfunctions by event-related potentials. World J Biol Psychiatry 1:112-118
16. Hegerl U, Gallinat J, Mrowinski D (1994) Intensity dependence of auditory evoked dipole source activity. Int J Psychophysiol 17:1-13 (Pubitemid 24217848)
17. Hegerl U, Gallinat J, Juckel G (2001) Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord 62:93-100 (Pubitemid 32126614)
18. Juckel G, Molnar M, Hegerl U, Csepe V, Karmos G (1997) Auditory-evoked potentials as indicator of brain serotonergic activity - first evidence in behaving cats. Biol Psychiatry 41:1181-1195 (Pubitemid 27237179)
19. Juckel G, Hegerl U, Giegling I, Mavrogiorgou P, Wutzler A, Schuhmacher C, Uhl I, Brune M, Mulert C, Pogarell O, Rujescu D (2008a) Association of 5-HT1B receptor polymorphisms with the loudness dependence of auditory evoked potentials in a community-based sample of healthy volunteers. Am J Med Genet B Neuropsychiatr Genet 147B:454-458 (Pubitemid 351830802)
20. Juckel G, Kawohl W, Giegling I, Mavrogiorgou P, Winter C, Pogarell O, Mulert C, Hegerl U, Rujescu D (2008b) Association of catechol-O- methyltransferase variants with loudness dependence of auditory evoked potentials. Hum Psychopharmacol 23:115-120 (Pubitemid 351359583)
21. Kawohl W, Waberski TD, Darvas F, Norra C, Gobbele R, Buchner H (2007) Comparative source localization of electrically and pressure-stimulated multichannel somatosensory evoked potentials. J Clin Neurophysiol 24:257-262 (Pubitemid 46871873)
22. Kawohl W, Giegling I, Mavrogiorgou P, Pogarell O, Mulert C, Moller HJ, Hegerl U, Rujescu D, Juckel G (2008a) Association of functional polymorphisms in NOS1 and NOS3 with loudness dependence of auditory evoked potentials. Int J Neuropsychopharmacol 11:477-483 (Pubitemid 351744810)
23. Kawohl W, Hegerl U, Muller-Oerlinghausen B, Juckel G (2008b) Insights in the central serotonergic function in patients with affective disorders. Neuropsychiatry 22:23-27 (Pubitemid 351684889)
24. Khor SP, Hsu A (2007) The pharmacokinetics and pharmacodynamics of levodopa in the treatment of Parkinson's disease. Curr Clin Pharmacol 2:234-243
25. Kumakura Y, Danielsen EH, Reilhac A, Gjedde A, Cumming P (2004) Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease. Acta Neurol Scand 110:188-195 (Pubitemid 39141291)
26. Lee TW, Yu YW, Chen TJ, Tsai SJ (2005) Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression. J Psychiatry Neurosci 30:202-205 (Pubitemid 40942459)
27. Lee IH, Yang YK, Chen PS, Huang HC, Yeh TL, Lu RB, Chiu NT, Yao WJ, Lin SH (2010) Loudness dependence of auditory evoked potentials (LDAEP) correlates with the availability of dopamine transporters and serotonin transporters in healthy volunteers - a two isotopes SPECT study. Psychopharmacology (Berl) 214:617-624
28. Meyer-Lindenberg A, Weinberger DR (2006) Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7:818-827 (Pubitemid 44435264)
29. Micallef-Roll J, Rihet P, Hasbroucq T, Possamai C, Blin O (2001) Levodopa-induced drowsiness in healthy volunteers: results of a choice reaction time test combined with a subjective evaluation of sedation. Clin Neuropharmacol 24:91-94 (Pubitemid 32294683)
30. Moret C, Briley M (2000) The possible role of 5-HT(1B/D) receptors in psychiatric disorders and their potential as a target for therapy. Eur J Pharmacol 404:1-12
31. Nicodemus KK, Kolachana BS, Vakkalanka R, Straub RE, Giegling I, Egan MF, Rujescu D, Weinberger DR (2007) Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Hum Genet 120:889-906 (Pubitemid 46128844)
32. Norra C, Mrazek M, Tuchtenhagen F, Gobbele R, Buchner H, Sass H, Herpertz SC (2003) Enhanced intensity dependence as a marker of low serotonergic neurotransmission in borderline personality disorder. J Psychiatr Res 37:23-33 (Pubitemid 35449768)
33. Norra C, Becker S, Brocheler A, Kawohl W, Kunert HJ, Buchner H (2008) Loudness dependence of evoked dipole source activity during acute serotonin challenge in females. Hum Psychopharmacol 23:31-42 (Pubitemid 351166066)
34. O'Neill BV, Croft RJ, Leung S, Guille V, Galloway M, Phan KL, Nathan PJ (2006) Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans. Psychopharmacology (Berl) 188:92-99 (Pubitemid 44268245)
35. O'Neill BV, Croft RJ, Nathan PJ (2008a) The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings. Hum Psychopharmacol 23:355-370
36. O'Neill BV, Guille V, Croft RJ, Leung S, Scholes KE, Phan KL, Nathan PJ (2008b) Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans. Hum Psychopharmacol 23:301-312 (Pubitemid 351982667)
37. Park YM, Kim DW, Kim S, Im CH, Lee SH (2011) The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder. Psychopharmacology (Berl) 213:625-632
38. Pogarell O, Tatsch K, Juckel G, Hamann C, Mulert C, Popperl G, Folkerts M, Chouker M, Riedel M, Zaudig M, Moller HJ, Hegerl U (2004) Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder. Neuropsychopharmacology 29:1910-1917 (Pubitemid 39336802)
39. Simmons JG, Nathan PJ, Berger G, Allen NB (2011) Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants. Psychopharmacology (Berl) 217:101-110
40. Uhl I, Gorynia I, Gallinat J, Mulert C, Wutzler A, Heinz A, Juckel G (2006) Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects? Hum Psychopharmacol 21:463-471 (Pubitemid 44660186)
41. Waberski TD, Gobbele R, Kawohl W, Cordes C, Buchner H (2003) Immediate cortical reorganization after local anesthetic block of the thumb: source localization of somatosensory evoked potentials in human subjects. Neurosci Lett 347:151-154 (Pubitemid 37271939)
42. Wyss C (2009) The role of central serotonergic activity in schizophrenic negative symptoms. Master Thesis, University of Zurich